on 14 Mar 2023
Last Applicant/ Owned by
2173 Salk Avenue, Suite 200
Carlsbad
CA
92008
Serial Number
90642829 filed on 13th Apr 2021
Registration Number
7001385 registered on 14th Mar 2023
Correspondent Address
Harold Milstein
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"CELL"
Pharmaceutical and biological research and development services in the field of cellular therapies, cell-based tissue regeneration and engineering, extracellular matrix biomaterial, cellular repair technology, cellular replacement therapy, cellular restoration therapy, cellular therapy delivery technology and cell culturing; Providing medical research information in the field of cellular therapiesRead More
Pharmaceutical and biological research and development services in the field of cellular therapies, cell-based tissue regeneration and engineering, extracellular matrix biomaterial, cellular repair technology, cellular replacement therapy, cellular restoration therapy, cellular therapy delivery technology and cell culturing; Providing medical research information in the field of cellular therapies, cell-based tissue regeneration and engineering, extracellular matrix biomaterial, cellular repair technology, cellular replacement therapy, cellular restoration therapy, cellular therapy delivery technology and cell culturing
17th Jan 2023
17th Jan 2023
No 90642829
No Service Mark
No 74YA-350506
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 14th Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
| 14th Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 09th Feb 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 08th Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Feb 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 07th Feb 2023 | SOU EXTENSION 1 GRANTED |
| 07th Feb 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 06th Feb 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Jan 2023 | TEAS STATEMENT OF USE RECEIVED |
| 18th Jan 2023 | SOU TEAS EXTENSION RECEIVED |
